Showing posts with label Cardiovascular. Show all posts
Showing posts with label Cardiovascular. Show all posts
Thursday, June 19, 2014
Sunday, June 8, 2014
Clevidipine
compared with nitroglycerin for blood pressure control in coronary artery
bypass grafting: a randomized double-blind study.
Can J
Anaesth. 2014 May;61(5):398-406
The investigators tested the hypothesis
that clevidipine, a rapidly acting dihydropyridine
calcium channel blocker, is not inferior to nitroglycerin (NTG) in controlling
blood pressure before cardiopulmonary bypass (CPB) during coronary artery
bypass grafting (CABG).
100 patients undergoing CABG with CPB were randomized at four centres to receive intravenous infusions of clevidipine (0.2-8 μg·kg(-1)·min(-1)) or NTG (0.4 μg·kg(-1)·min(-1) to a clinician-determined maximum dose rate) from induction of anesthesia through 12 hr postoperatively.
The study drug was titrated in the pre-CPB period with the aim of maintaining mean arterial pressure (MAP) within ± 5 mmHg of a clinician-predetermined target.
Total mean [standard
deviation (SD)] dose pre-bypass was 4.5 (4.7) mg for clevidipine and 6.9 (5.4) mg for NTG
(P < 0.05).
CONCLUSION:
During CABG, clevidipine was not inferior to NTG for blood pressure control pre-bypass.Thursday, June 5, 2014
Carotid endarterectomy under local and/or
regional anesthesia has less risk of
myocardial infarction compared to general anesthesia: An analysis of
national surgical quality improvement program database.
.
Vascular. 2014 May 29.
Our study compared 30-day postoperative myocardial infarction, stroke, and
mortality between carotid endarterectomy under local or regional anesthesia and carotid endarterectomy
under general anesthesia utilizing National Surgical Quality Improvement Program database
Carotid endarterectomy under local or regional anesthesia had a significantly decreased
risk of 30-day postoperative myocardial infarction when compared to carotid
endarterectomy under general anesthesia (0.4% vs 0.86%, p = 0.012). No statistically
significant differences were found in postoperative stroke or mortality.
Saturday, May 31, 2014
Hypothermic vs normothermic cardiopulmonary bypass on patients with valvular heart disease
Vladimir V Lomivorotov et al
Journal of Cardiothoracic and Vascular Anesthesia
Volume 28, Issue 2 , Pages 295-300, April 2014
Prospective randomized study.
140 patients who had valvular heart disease, with/without coronary artery disease, surgically treated under CPB.
Normothermic CPB in patients with valvular heart disease was as effective as hypothermic perfusion in terms of myocardial protection after the surgery assessed by cTnI release.
Ventilation time was significantly lower in the hypothermic group
Vladimir V Lomivorotov et al
Journal of Cardiothoracic and Vascular Anesthesia
Volume 28, Issue 2 , Pages 295-300, April 2014
Prospective randomized study.
140 patients who had valvular heart disease, with/without coronary artery disease, surgically treated under CPB.
Normothermic CPB in patients with valvular heart disease was as effective as hypothermic perfusion in terms of myocardial protection after the surgery assessed by cTnI release.
Ventilation time was significantly lower in the hypothermic group
Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery
Fuhai Ji et al
Journal of Cardiothoracic and Vascular Anesthesia
Volume 28, Issue 2 , Pages 267-273, April 2014
Retrospective investigation.
Perioperative dexmedetomidine was used as an intravenous infusion (0.24 to 0.6 µg/kg/hour) initiated after cardiopulmonary bypass and continued for less than 24 hours postoperatively in the intensive care unit.
Dexmedetomidine infusion during CABG surgery was more likely to achieve improved in-hospital, 30-day, and 1-year survival rates, and a significantly lower incidence of delirium.
Fuhai Ji et al
Journal of Cardiothoracic and Vascular Anesthesia
Volume 28, Issue 2 , Pages 267-273, April 2014
Retrospective investigation.
Perioperative dexmedetomidine was used as an intravenous infusion (0.24 to 0.6 µg/kg/hour) initiated after cardiopulmonary bypass and continued for less than 24 hours postoperatively in the intensive care unit.
Dexmedetomidine infusion during CABG surgery was more likely to achieve improved in-hospital, 30-day, and 1-year survival rates, and a significantly lower incidence of delirium.
Effect of adding statins before surgery on mortality and major morbidity : a meta analysis
Joanne Guay et al
Journal of Cardiothoracic and Vascular Anesthesia
Volume 28, Issue 2 , Pages 255-266, April 2014
A search for all randomized controlled trials ,adult patients undergoing any type of procedure.
The search produced 29 trials.
Statins reduced the 0-30 days’ risk of myocardial infarction: risk ratio (RR) 0.48 (95%CI 0.38, 0.61); I-square 13.2%; p<0.001; number needed-to-treat 17 (14, 24)
There were no statistical differences at 0-30 days for stroke , acute renal insufficiency or reoperation. There was a trend for a reduced mortality at 1 year.
Joanne Guay et al
Journal of Cardiothoracic and Vascular Anesthesia
Volume 28, Issue 2 , Pages 255-266, April 2014
A search for all randomized controlled trials ,adult patients undergoing any type of procedure.
The search produced 29 trials.
Statins reduced the 0-30 days’ risk of myocardial infarction: risk ratio (RR) 0.48 (95%CI 0.38, 0.61); I-square 13.2%; p<0.001; number needed-to-treat 17 (14, 24)
There were no statistical differences at 0-30 days for stroke , acute renal insufficiency or reoperation. There was a trend for a reduced mortality at 1 year.
Sunday, May 18, 2014
General anesthesia soon after dialysis may increase postoperative hypotension - A pilot study
J Deng, J Lenart, and R L Applegate
Heart Lung Vessel. 2014; 6(1): 52–59.
Post-anesthetic hypotension within 48 hours was more common in those with < 7 hours interval between dialysis and anesthesia. Therefore, if surgical urgency permits, a delay of ≥7 hours may limit postoperative hypotension
Saturday, May 17, 2014
Clonidine in Patients Undergoing Noncardiac Surgery
P.J. Devereaux, M.D et al
N Engl J Med 2014; 370:1504-1513April 17, 2014
Administration of low-dose clonidine in patients undergoing noncardiac surgery did not reduce the rate of the composite outcome of death or nonfatal myocardial infarction; it did, however, increase the risk of clinically important hypotension and nonfatal cardiac arrest.
Thursday, May 15, 2014
Central venous oxygen saturation and carbon dioxide gap as resuscitation targets in a hemorrhagic shock
M. NÉMETH,K. TÁNCZOS,G. DEMETER,D. ÉRCES,J. KASZAKI,A. MIKOR,Z. MOLNÁR
Acta Anaesthesiologica Scandinavica Volume 58, Issue 5, pages 611–619, May 2014
In this SV-guided bleeding and fluid resuscitation model, both ScvO2 and dCO2 correlated well with changes in SV, but only the dCO2 returned to its baseline, normal value, while ScvO2 remained significantly lower than at baseline. These results suggest that dCO2( venous-to-arterial carbon dioxide gap ) may be a good hemodynamic endpoint of resuscitation, while ScvO2 is not strictly a hemodynamic parameter, but rather an indicator of the balance between oxygen delivery and consumption.
The Risk of Hypertension after Preoperative
Discontinuation of Angiotensin-Converting Enzyme
Inhibitors or Angiotensin Receptor Antagonists
in Ambulatory and Same-Day Admission Patients
Rebecca S. Twersky, MD, MPH, Vasudha Goel, MD, Preeti Narayan, MD,
and Jeremy Weedon, PhD, MA, BS
Anesth Analg 2014;118:938–44
Discontinuing ACEIs and ARBs in patients on the day of surgery did not result
in a substantively increased incidence of pre- or postoperative HTN compared with patients who
continued these medications on the day of surgery. The results provide an evidentiary basis for
the safety of discontinuing ACEIs and ARBs on the day of surgery without increasing adverse
hemodynamic outcomes.
Subscribe to:
Posts (Atom)